Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Countries and organisations
Explore psilocybin trials by country, sponsor and research facility. Compare registry status, study-start trends, conditions and mapped research sites.
Free access · No subscription for research tools or data exports
Explore registry geography and organisations
2 trials match this view; 29 mapped facilities. Latest indexed registry check Oct 9, 2026 01:24 UTC. Country membership uses reported locations, including locations without coordinates; Mapped-facility counts cover all sites of matching trials, including international sites, and require valid coordinates.
Enrollment sum: 341 across 2 records with a reported count. Planned and actual counts are mixed; this is not a count of unique treated participants.
Recorded study-start years
Current indexed registry status
Reported research conditions
Counts describe indexed registry records, not efficacy or total research activity. A trial can count under several conditions or countries. Unknown dates are excluded from the start-year chart; future years reflect planned starts. Stopped studies may reflect recruitment, funding or strategy and are not automatically treatment failures.
Matching trial records
| Trial | Sponsor and phase | Status | Enrollment | Start / primary completion / completion | Research workflow |
|---|---|---|---|---|---|
| The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.COPD (Chronic Obstructive Pulmonary Disease) · ALS (Amyotrophic Lateral Sclerosis) · MS (Multiple Sclerosis) · Major Depressive Disorder (MDD) · Atypical Parkinson Disease | University Medical Center Groningen PHASE2 | Recruiting Registry updated 2026-05-08 | 108 ESTIMATED | 2025-07-01 2027-01-01 2028-01-01 | |
| The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant DepressionTreatment Resistant Depression | COMPASS Pathways PHASE2 | Completed Registry updated 2023-04-24 | 233 ACTUAL | 2019-03-01 2021-07-30 2021-09-27 |
Reported research facilities
National Institute of Mental HealthPrague, Czechia
Bispebjerg HospitalCopenhagen, Denmark
University Medical Center GroningenGroningen, Provincie Groningen, Netherlands
Champalimaud FoundationLisbon, Portugal
Kadima Neuropsychiatry InstituteLa Jolla, California, United States
Altman Clinical and Translational Research Institute, University of CaliforniaSan Diego, California, United States
Stanford Department of PsychiatryStanford, California, United States
Mood and Anxiety Disorders Program Emory University School of MedicineAtlanta, Georgia, United States
Ray Worthy Psychiatry LLCNew Orleans, Louisiana, United States
Sheppard Pratt Health SystemBaltimore, Maryland, United States
New York State Psychiatric InstituteNew York, New York, United States
UT Center of Excellence on Mood Disorders, University of Texas Health Science CenterHouston, Texas, United States
Canadian Rapid Treatment Centre of ExcellenceMississauga, Ontario, Canada
Centre for Addiction and Mental HealthToronto, Ontario, Canada
National Institute of Mental Health Czech RepublicKlecany, Czechia
Enhed for Psykiatrisk Forskning, Psykiatrien i AalborgAalborg, Denmark
Charité - Universitätsmedizin Berlin, Department of Psychiatry and Psychotherapy, Campus Benjamin FranklinBerlin, Germany
Tallaght University HospitalDublin, Ireland
Groningen University Medical CentreGroningen, Netherlands
Leiden University Medical CentreLeiden, Netherlands
Utrecht University Medical CentreUtrecht, Netherlands
Unidade de Neuropsiquiatria, Centro Clinico ChampalimaudLisbon, Portugal
Hospital de Dia NumanciaBarcelona, Spain
Institute Hospital del Mar of Medical Research (IMIM)Barcelona, Spain
Clinical Research and Imaging CentreBristol, Avon, United Kingdom
Wolfson Research Centre, Campus for Ageing and VitalityNewcastle upon Tyne, Tyne and Wear, United Kingdom
St. Pancras Clinical ResearchLondon, United Kingdom
Kings College London, Institute of Psychiatry, Psychology and NeurologyLondon, United Kingdom
Greater Manchester Mental Health Foundation TrustManchester, United Kingdom
This list includes mapped sites of matching trials, including international sites; locations without usable coordinates are omitted. Facilities are registry-reported trial sites, not an independently verified clinic or research-centre directory. Current services and contact details must be checked at the source.